72 related articles for article (PubMed ID: 18409660)
21. [Preliminary results of tumor marker monitoring in patients with colorectal carcinoma].
Caramanico L; Cavaleri V; Costi U; Palloni T; Volpe M; Parnofiello A
Minerva Chir; 1989 Apr; 44(7):1135-8. PubMed ID: 2747957
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery].
Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P
Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670
[TBL] [Abstract][Full Text] [Related]
23. [Pancreatic cancer screening: mission impossible?].
Bartel M; Friess H
Z Gastroenterol; 2006 Nov; 44(11):1181-2. PubMed ID: 17115361
[No Abstract] [Full Text] [Related]
24. [After-care of colorectal carcinoma--value of tumor markers].
Köhne CH; Benter T
Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
[No Abstract] [Full Text] [Related]
25. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
Draghici S; Chatterjee M; Tainsky MA
Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
[TBL] [Abstract][Full Text] [Related]
26. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
Yuan M; Xhang X; Leu Y; Xu Y; Ullah N; Lawson M; Tobi M
Cancer Lett; 2006 Apr; 235(1):48-52. PubMed ID: 15893419
[TBL] [Abstract][Full Text] [Related]
27. TAG-72 expression and its role in the biological evaluation of human colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Cavaliere F; Arcuri R; Carlini S; Mariotti S; Gandolfo GM; Casciani CU; Greiner JW; Schlom J
Anticancer Res; 1996; 16(4B):2141-8. PubMed ID: 8694534
[TBL] [Abstract][Full Text] [Related]
28. New test detects early prostate cancer.
Health News; 2005 Sep; 11(9):9. PubMed ID: 16208809
[No Abstract] [Full Text] [Related]
29. [Detection of colorectal findings for cancer prevention by immunochemical stool test with different sensitivity levels].
Brenner G; Faure H; Heuer S; Reinholz J
Z Gastroenterol; 2012 Oct; 50(10):1083-8. PubMed ID: 23059801
[TBL] [Abstract][Full Text] [Related]
30. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
31. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
Grandjean M; Dieu M; Raes M; Feron O
J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
[TBL] [Abstract][Full Text] [Related]
32. Screening for colorectal cancer: a guidance statement from the American College of Physicians.
Qaseem A; Denberg TD; Hopkins RH; Humphrey LL; Levine J; Sweet DE; Shekelle P;
Ann Intern Med; 2012 Mar; 156(5):378-86. PubMed ID: 22393133
[TBL] [Abstract][Full Text] [Related]
33. Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS.
Zheng GX; Wang CX; Qu X; Deng XM; Deng BP; Zhang J
Exp Oncol; 2006 Dec; 28(4):282-7. PubMed ID: 17285111
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive testing for colorectal cancer: a review.
Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
[TBL] [Abstract][Full Text] [Related]
35. Blood tests for protein biomarkers show promise.
Printz C
Cancer; 2010 Jun; 116(11):2505-6. PubMed ID: 20499397
[No Abstract] [Full Text] [Related]
36. Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel.
Chen Z; Li M; Yuan Y; Wang Q; Yan L; Gu J
Dis Colon Rectum; 2010 Jan; 53(1):31-8. PubMed ID: 20010347
[TBL] [Abstract][Full Text] [Related]
37. Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
Herbst A; Rahmig K; Stieber P; Philipp A; Jung A; Ofner A; Crispin A; Neumann J; Lamerz R; Kolligs FT
Am J Gastroenterol; 2011 Jun; 106(6):1110-8. PubMed ID: 21326223
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of a novel anti-colorectal cancer monoclonal antibody, WL5.
Liu J; Di G; Wu CT; Hu X; Duan H
Biochem Biophys Res Commun; 2013 Mar; 432(2):370-7. PubMed ID: 23376714
[TBL] [Abstract][Full Text] [Related]
39. The promise of biological markers as prognostic determinants in colorectal cancer.
Johnston PG
Onkologie; 2005 Aug; 28(8-9):388-9. PubMed ID: 16160400
[No Abstract] [Full Text] [Related]
40. [Tumor marker and its clinical significance in diagnosis of colorectal cancer].
Imai Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():193-6. PubMed ID: 14574880
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
